Longeveron Inc. (LGVN)
Last updated: 2026-10-24 23:04:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Longeveron Inc. (LGVN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.58, with a market capitalization of $5.07M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $12.30. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$5.07M | |
$1.58 | |
$4,500.00 | |
$1.31 | |
$1.59 | |
62.69K | |
104.49K | |
-- | |
$12.30 | |
$1.31 | |
-- | |
-- |
Longeveron Inc. (LGVN) Latest Closing Stock Price
Longeveron Inc. (LGVN) last closed at $1.59 as of 2026-10-23 23:31:00, unchanged from the previous close of $1.59.
During the latest regular trading session, LGVN traded between $1.31 and $4,500.00, with a volume of 62.69K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Longeveron Inc. (LGVN) 7-Day Stock Price Change
Over the past seven days, Longeveron Inc. (LGVN) moved from $1.50 to $1.58, representing a gain of 5.00% ($0.07).
The stock traded between $1.31 and $1.71 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 77.64 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
LGVN 52-Week Price Position
Position in Range: 2.4%
LGVN is currently trading at $1.58, placing it 2.4% of the way from its 52-week low of $1.31 to its 52-week high of $12.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Longeveron Inc. (LGVN)?
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
Longeveron Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 38 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Longeveron Inc. (LGVN) Stock on MEXC
Eligible investors can buy real shares of Longeveron Inc. (LGVN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Longeveron Inc. (LGVN) stock price today?
2.Is LGVN stock going up or down today?
3.What is LGVN pre-market price?
4.What is LGVN after-hours price?
5.Is LGVN stock trading now?
6.Where does LGVN sit relative to its 52-week high and low?
7.What sector is Longeveron Inc. in?
8.What is Longeveron Inc.'s market capitalization and where is it listed?
9.How is LGVN valued in terms of P/E ratio and EPS?
10.Does Longeveron Inc. pay a dividend?
Explore More US Stocks
Search Stocks
LGVN Stock Calculator
Estimate the value between LGVN shares and USD.
LGVN Shares to USD
1.00 LGVN shares = 1.575 USD
Calculations are estimates based on the latest available price and are for reference only.


